VAXESS TECHNOLOGIES
Vaxess Technologies is developing the MIMIX™ sustained release patch technology, the easiest and most effective way to administer vaccines and therapeutics. For vaccines, the controlled release simulates the pace of a natural infection, helping the body produce a slow, strong, and enduring ramp-up of immune response, ultimately boosting a vaccine’s effectiveness. Engineered for stability, Vaxess’s patch does not require refrigeration and can be shipped to and applied in low resource settings.
VAXESS TECHNOLOGIES
Industry:
Biotechnology Health Care Medical
Founded:
2012-07-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vaxess.com
Total Employee:
51+
Status:
Active
Contact:
614-507-9586
Email Addresses:
[email protected]
Total Funding:
86.87 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Font API Content Delivery Network LetsEncrypt SSL By Default HSTS IPv6
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Amae Health
Amae Health is a wellness clinic that offers care for people with mental illness.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Hertility Health
Hertility Health is on a mission to revolutionise the world of reproductive health.
PeerBridge Health
Peerbridge Health is developing the next generation of wearable wireless vital sign monitoring technology.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
TrueBinding
TrueBinding is an early-stage biotherapeutics development company that focuses on creating new and exciting molecules for applications.
Current Advisors List
Current Employees Featured
Founder
Investors List
Mission BioCapital
Mission BioCapital investment in Venture Round - Vaxess Technologies
Engine Ventures
Engine Ventures investment in Venture Round - Vaxess Technologies
RA Capital Management
RA Capital Management investment in Venture Round - Vaxess Technologies
Global Health Investment Corporation
Global Health Investment Corporation investment in Venture Round - Vaxess Technologies
The Engine
The Engine investment in Venture Round - Vaxess Technologies
Global Health Investment Corporation
Global Health Investment Corporation investment in Venture Round - Vaxess Technologies
RA Capital Management
RA Capital Management investment in Venture Round - Vaxess Technologies
Ulu Ventures
Ulu Ventures investment in Venture Round - Vaxess Technologies
Mission BioCapital
Mission BioCapital investment in Series B - Vaxess Technologies
The Engine
The Engine investment in Series B - Vaxess Technologies
Official Site Inspections
http://www.vaxess.com Semrush global rank: 3.71 M Semrush visits lastest month: 3.28 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Vaxess Technologies"
Vaxess Technologies
Vaxess is forging a path to more convenient, self-empowered, and accessible healthcare by transforming delivery of next-gen therapies and vaccines. Vaxess engineers novel …See details»
Vaxess Technologies - Wikipedia
Vaxess Technologies, Inc. is a company started by a team of four graduate students from Harvard developing a suite of vaccines on the MIMIX sustained dermal delivery platform that combines high temperature stability, improved efficacy, and simplified delivery to improve global vaccine access. See details»
News – News: Vaxess Announces $12M in Funding | Vaxess
CAMBRIDGE, Mass., May 22, 2024 — Vaxess Technologies, Inc., a life sciences company developing a shelf-stable MIMIX skin patch for vaccines and therapeutics, today announced …See details»
Our Team | Vaxess
Vaxess is forging a path to more convenient, self-empowered, and accessible healthcare by transforming delivery of next-gen therapies and vaccines. We are a group of life scientists, …See details»
Vaxess Technologies - LinkedIn
Engineering Immunity for All | Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on...See details»
Vaxess Technologies, Inc. - BIO International Convention | BIO
Jun 6, 2023 · Vaxess Technologies is developing the MIMIXâ„¢ sustained release patch technology, the easiest and most effective way to administer vaccines and therapeutics.See details»
Vaxess Technologies, Inc. | STEX - Startup
Apr 13, 2020 · Vaxess Technologies is a venture-backed biotechnology company developing novel products based on its proprietary MIMIX microneedle delivery platform. Our lead …See details»
Vaxess Technologies Company Profile 2024: Valuation, …
Developer of novel therapies designed to help in oncology care and infectious diseases. The company's therapies provide long-term cancer immunity, clearance of distant tumors and compatibility with antigens, enabling healthcare …See details»
Our Approach | Vaxess
Vaxess is forging a path to more convenient, self-empowered, and accessible healthcare by transforming delivery of next-gen therapies and vaccines. Our Mission is to engineer more effective and accessible vaccines and …See details»
Get to Know Past NVC Winners: Vaxess - Harvard …
Feb 11, 2022 · What inspired you to start your company or organization? We built Vaxess to solve the problem of inequitable vaccine access. More than 2.4 million people around the world are dying from diseases for which we have a high …See details»
Vaxess Technologies | STEX - Startup
Apr 13, 2020 · Because of the pandemic, Vaxess’s focus has been on making a combination vaccine for COVID and influenza. The company could have never predicted that this would be its work when it started, or even in 2019, but it …See details»
Technological Innovation for Global Health: Vaxess’ Long Road to …
Sep 30, 2016 · Together with colleagues, Harvard Kennedy School graduate Livio Valenti had founded the start-up company Vaxess to develop a silk-based technology that was very …See details»
Vaxess Technologies Receives Grants Totaling $6 Million to …
Mar 6, 2017 · Vaxess is commercializing the MIMIXâ„¢ microneedle platform for sustained transdermal delivery of vaccines and therapies and the MATRIX formulation and drying …See details»
Vaxess Technologies, Inc. | Consumers, Corporations, and Public …
'Vaxess Technologies, Inc.', in John A. Quelch (ed.), Consumers, Corporations, and Public Health: A Case-Based Approach to Sustainable Business (New York, 2016; online edn, Oxford …See details»
Partnerhips | Vaxess
Vaxess is forging a path to more convenient, self-empowered, and accessible healthcare by transforming delivery of next-gen therapies and vaccines. We are proud that leading …See details»
Vaxess Technologies Inc. | Bill & Melinda Gates Foundation
Vaxess Technologies Inc. Grantee website Boston, MA, United States Purpose. to support the preclinical development and manufacture of a thermostable microneedle patch with the aim of …See details»
Technological Innovation for Global Health: Vaxess' Long Road to …
Vaxess aims to increase vaccine access for children living in low-income countries, particularly in rural areas. This case examines the complex global system that shapes the process of …See details»
News & Press Releases - Vaxess
Aug 16, 2013 · Vaxess is forging a path to more convenient, self-empowered, and accessible healthcare by transforming delivery of next-gen therapies and vaccines.See details»
Meet The Disruptors: Michael Schrader Of Vaxess On The Five
Oct 7, 2022 · Vaxess is working towards a future where vaccines for the majority of illnesses — from flu to COVID — move out of the clinic and into remote locations, ranging from workplaces …See details»
Rachel Sha | Vaxess
Rachel holds a MBA from the Harvard Business School and a B.S. in Chemistry from the Massachusetts Institute of Technology. Vaxess is forging a path to more convenient, self …See details»